Cargando…

Clinicopathological and Prognostic Characteristics of CD276 (B7-H3) Expression in Adrenocortical Carcinoma

BACKGROUND: Adrenocortical carcinoma (ACC) is a rare malignant endocrine tumor with a high tumor recurrence rate and poor postoperative survival. Recent studies suggest that CD276- (B7-H3) targeted therapy represents a promising therapeutic option for solid tumors. However, little is known about the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liang, Jiayu, Liu, Zhihong, Pei, Tianjiao, Xiao, Yingming, Zhou, Liang, Tang, Yongquan, Zhou, Chuan, Wu, Kan, Zhang, Fuxun, Zhang, Fan, Yin, Xiaoxue, Chen, Ni, Wei, Xin, Lu, Yiping, Zhu, Yuchun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6977319/ https://www.ncbi.nlm.nih.gov/pubmed/31998416 http://dx.doi.org/10.1155/2020/5354825

Ejemplares similares

Expression of FSCN1 and FOXM1 are associated with poor prognosis of adrenocortical carcinoma patients
por: Liang, Jiayu, et al.
Publicado: (2019)

The Role of CD276 in Cancers
por: Liu, Shengzhuo, et al.
Publicado: (2021)

Association between preoperative serum albumin and prognosis in patients with adrenocortical carcinoma after primary resection: a retrospective study
por: Zhang, Fuxun, et al.
Publicado: (2021)

Reoperation for Recurrent Adrenocortical Carcinoma: A Systematic Review and Pooled Analysis of Population-Based Studies
por: Zhang, Fan, et al.
Publicado: (2022)

Expression of glucocorticoid receptor (GR) and clinical significance in adrenocortical carcinoma
por: Wu, Kan, et al.
Publicado: (2022)

Benefits of Adjuvant Mitotane after Resection of Adrenocortical Carcinoma: A Systematic Review and Meta-Analysis
por: Tang, Yongquan, et al.
Publicado: (2018)

Early post-operative serum albumin level predicts survival after curative nephrectomy for kidney cancer: a retrospective study
por: Tang, Yongquan, et al.
Publicado: (2018)

Knockdown of ribosomal protein S15A inhibits human kidney cancer cell growth in vitro and in vivo
por: Liang, Jiayu, et al.
Publicado: (2019)

Discovery of a glucocorticoid receptor (GR) activity signature correlates with immune cell infiltration in adrenocortical carcinoma
por: Wu, Kan, et al.
Publicado: (2023)

Macrophage-Specific Cathepsin as a Marker Correlated with Prognosis and Tumor Microenvironmental Characteristics of Clear Cell Renal Cell Carcinoma
por: Zhang, Fan, et al.
Publicado: (2022)

Clinical significance of prognostic nutritional index in renal cell carcinomas
por: Tang, Yongquan, et al.
Publicado: (2021)

The Correlation Between the Immune and Epithelial-Mesenchymal Transition Signatures Suggests Potential Therapeutic Targets and Prognosis Prediction Approaches in Kidney Cancer
por: Liang, Jiayu, et al.
Publicado: (2018)

Prognostic Significance of CD276 in Non-small Cell Lung Cancer
por: Zhang, Changgong, et al.
Publicado: (2019)

A Clinicopathological Analysis of Asian Patients with Adrenocortical Carcinoma: A Single-Center Experience
por: Tsai, Wen-Hsuan, et al.
Publicado: (2023)

B7-H3/CD276: An Emerging Cancer Immunotherapy
por: Zhou, Wu-Tong, et al.
Publicado: (2021)

Clinicopathological features and outcomes of adrenocortical carcinoma: A single institution experience
por: Nair, Lekha Madhavan, et al.
Publicado: (2019)

Differentiating Benign from Malignant Adrenocortical Tumors by a Single Morphological Parameter—a Clinicopathological Study on 837 Adrenocortical Neoplasias
por: Walz, Martin K., et al.
Publicado: (2020)

Multi-omics analyses of CD276 in pan-cancer reveals its clinical prognostic value in glioblastoma and other major cancer types
por: Dai, Lirui, et al.
Publicado: (2023)

Steroid metabolites for diagnosing and predicting clinicopathological features in cortisol-producing adrenocortical carcinoma
por: Suzuki, Sawako, et al.
Publicado: (2020)

Integrated Analysis of Energy Metabolism Signature-Identified Distinct Subtypes of Bladder Urothelial Carcinoma
por: Zhang, Fan, et al.
Publicado: (2022)

Comprehensive analysis of alternative polyadenylation regulators concerning CD276 and immune infiltration in bladder cancer
por: Xiong, Ming, et al.
Publicado: (2022)

CD276-CAR T cells and Dual-CAR T cells targeting CD276/FGFR4 promote rhabdomyosarcoma clearance in orthotopic mouse models
por: Timpanaro, Andrea, et al.
Publicado: (2023)

Serum uric acid as a risk factor for rejection after deceased donor kidney transplantation: A mono-institutional analysis of paired kidneys
por: Zhang, Fuxun, et al.
Publicado: (2022)

Prognostic Alternative mRNA Splicing in Adrenocortical Carcinoma
por: Liang, Weiwei, et al.
Publicado: (2021)

A CD276-Targeted Antibody-Drug Conjugate to Treat Non-Small Lung Cancer (NSCLC)
por: Zhang, Jiashuai, et al.
Publicado: (2023)

The prognostic value and immunological role of SULF2 in adrenocortical carcinoma
por: Yan, Jiusong, et al.
Publicado: (2023)

Prognostic predictors of adrenocortical carcinoma: A single-center thirty-year experience
por: Pan, Li-Hsin, et al.
Publicado: (2023)

A risk assessment model of acute liver allograft rejection by genetic polymorphism of CD276
por: Yu, Xiaobo, et al.
Publicado: (2019)

CD276 Promotes Vasculogenic Mimicry Formation in Hepatocellular Carcinoma via the PI3K/AKT/MMPs Pathway
por: Cheng, Rui, et al.
Publicado: (2020)

Risk factors and survival outcomes of metachronous contralateral upper tract urothelial carcinoma
por: Wu, Kan, et al.
Publicado: (2020)

Screening and Identification of Potential Prognostic Biomarkers in Adrenocortical Carcinoma
por: Xu, Wen-Hao, et al.
Publicado: (2019)

Identification of the ferroptosis regulator HELLS with prognostic value for adrenocortical carcinoma based on integrated analysis and experimental validation
por: Liu, Zijian, et al.
Publicado: (2023)

Genetic and clinical characterization of B7‐H3 (CD276) expression and epigenetic regulation in diffuse brain glioma
por: Wang, Zhiliang, et al.
Publicado: (2018)

Clinicopathological features of superficial CD34-positive fibroblastic tumor
por: Ding, Li, et al.
Publicado: (2021)

Expression patterns of the immune checkpoint ligand CD276 in urothelial carcinoma
por: Aicher, Wilhelm K., et al.
Publicado: (2021)

CD276 as a Candidate Target for Immunotherapy in Medullary Thyroid Cancer
por: Hińcza-Nowak, Kinga, et al.
Publicado: (2023)

Decreased m6A Modification of CD34/CD276(B7-H3) Leads to Immune Escape in Colon Cancer
por: Zhou, Yiran, et al.
Publicado: (2021)

New frontiers in immune checkpoint B7-H3 (CD276) research and drug development
por: Getu, Ayechew Adera, et al.
Publicado: (2023)

CD10-positive mantle cell lymphoma: clinicopathologic and prognostic study of 30 cases
por: Xu, Jie, et al.
Publicado: (2017)

Gene clusters based on OLIG2 and CD276 could distinguish molecular profiling in glioblastoma
por: Fu, Minjie, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_msdurt4d91h8gsue7gls4dr3j7